Form 4: Guardant Health Director Myrtle S. Potter Reports Stock Transactions

Director Myrtle S. Potter reports the acquisition of 68 shares of Guardant Health, Inc. common stock on June 15, 2024, through the vesting of restricted stock units.

Summary

• On June 15, 2024, Myrtle S. Potter, a director of Guardant Health, Inc., acquired 68 shares of common stock.
• The acquisition was a result of the vesting of restricted stock units.
• The price per share was $0.
• Following the transaction, Potter directly owns 13,311 shares of Guardant Health, Inc.
• Potter also directly owns 1,095 derivative securities.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Positives

• The acquisition of shares by a director could be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. They provide insights into the buying and selling activities of company insiders, such as directors and officers.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it reflects insider activity, which can influence investor sentiment.

Key Dates